Open AccessP827: EFFICACY AND SAFETY OF ROMIPLOSTIM ADDED TO IMMUNOSUPPRESSIVE THERAPY AS A FIRST‐LINE TREATMENT IN PATIENTS WITH APLASTIC ANEMIA: A PHASE 2/3 CLINICAL TRIAL
Author(s) -
Yamazaki H.,
Lee J. W.,
Jang J. H.,
Sawa M.,
Kizaki M.,
Tomiyama Y.,
Nagafuji K.,
Usuki K.,
Gau J.P.,
Morita Y.,
Tang J.L.,
Chang H.,
Noshiro M.,
Matsuda A.,
Ozawa K.,
Mitani K.,
Kanda Y.,
Nakao S.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000846192.06541.42
Subject(s) - romiplostim , medicine , eltrombopag , thrombopoietin , aplastic anemia , clinical endpoint , anemia , clinical trial , refractory (planetary science) , surgery , pediatrics , bone marrow , haematopoiesis , immune thrombocytopenia , platelet , genetics , stem cell , biology , physics , astrobiology